RegentAtlantic Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $834K | Sell |
1,999
-107
| -5% | -$44.6K | 0.02% | 347 |
|
|
2022
Q2 | $1.04M | Sell |
2,106
-47
| -2% | -$23.3K | 0.03% | 307 |
|
|
2022
Q1 | $1.21M | Sell |
2,153
-63
| -3% | -$35.5K | 0.03% | 285 |
|
|
2021
Q4 | $1.67M | Sell |
2,216
-72
| -3% | -$54.4K | 0.05% | 245 |
|
|
2021
Q3 | $1.71M | Sell |
2,288
-204
| -8% | -$152K | 0.05% | 226 |
|
|
2021
Q2 | $1.61M | Sell |
2,492
-110
| -4% | -$70.9K | 0.05% | 232 |
|
|
2021
Q1 | $1.49M | Sell |
2,602
-213
| -8% | -$122K | 0.05% | 225 |
|
|
2020
Q4 | $2K | Sell |
2,815
-52
| -2% | -$37 | ﹤0.01% | 503 |
|
|
2020
Q3 | $1.48M | Buy |
2,867
+26
| +0.9% | +$13.4K | 0.07% | 185 |
|
|
2020
Q2 | $1.28M | Buy |
2,841
+223
| +9% | +$101K | 0.07% | 194 |
|
|
2020
Q1 | $918K | Buy |
2,618
+317
| +14% | +$111K | 0.07% | 212 |
|
|
2019
Q4 | $851K | Buy |
2,301
+408
| +22% | +$151K | 0.05% | 255 |
|
|
2019
Q3 | $630K | Sell |
1,893
-77
| -4% | -$25.6K | 0.04% | 273 |
|
|
2019
Q2 | $616K | Sell |
1,970
-33
| -2% | -$10.3K | 0.04% | 273 |
|
|
2019
Q1 | $612K | Buy |
2,003
+12
| +0.6% | +$3.67K | 0.04% | 267 |
|
|
2018
Q4 | $462K | Buy |
1,991
+1,283
| +181% | +$298K | 0.04% | 291 |
|
|
2018
Q3 | $222K | Buy |
+708
| New | +$222K | 0.02% | 409 |
|
|
2015
Q1 | – | Sell |
-238
| Closed | -$28.7K | – | 418 |
|
|
2014
Q4 | $28.7K | Buy |
+238
| New | +$28.7K | ﹤0.01% | 687 |
|